Correlation Between Seres Therapeutics and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Inhibrx, you can compare the effects of market volatilities on Seres Therapeutics and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Inhibrx.
Diversification Opportunities for Seres Therapeutics and Inhibrx
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Seres and Inhibrx is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Inhibrx go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Inhibrx
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 2.54 times more return on investment than Inhibrx. However, Seres Therapeutics is 2.54 times more volatile than Inhibrx. It trades about 0.16 of its potential returns per unit of risk. Inhibrx is currently generating about -0.03 per unit of risk. If you would invest 70.00 in Seres Therapeutics on August 29, 2024 and sell it today you would earn a total of 18.00 from holding Seres Therapeutics or generate 25.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Inhibrx
Performance |
| Timeline |
| Seres Therapeutics |
| Inhibrx |
Seres Therapeutics and Inhibrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Inhibrx
The main advantage of trading using opposite Seres Therapeutics and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Inhibrx vs. Eliem Therapeutics | Inhibrx vs. Scpharmaceuticals | Inhibrx vs. Milestone Pharmaceuticals | Inhibrx vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |